0001493152-24-037731.txt : 20240920 0001493152-24-037731.hdr.sgml : 20240920 20240920211547 ACCESSION NUMBER: 0001493152-24-037731 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240919 FILED AS OF DATE: 20240920 DATE AS OF CHANGE: 20240920 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KOSKI ROBERT C CENTRAL INDEX KEY: 0001234880 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32188 FILM NUMBER: 241314481 MAIL ADDRESS: STREET 1: 1500 W UNIVERSITY PARKWAY CITY: SARASOTA STATE: FL ZIP: 34243 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ORAGENICS INC CENTRAL INDEX KEY: 0001174940 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 593410522 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1990 MAIN STREET STREET 2: SUITE 750 CITY: SARASOTA STATE: FL ZIP: 34236 BUSINESS PHONE: 8132867900 MAIL ADDRESS: STREET 1: 1990 MAIN STREET STREET 2: SUITE 750 CITY: SARASOTA STATE: FL ZIP: 34236 4 1 ownership.xml X0508 4 2024-09-19 0 0001174940 ORAGENICS INC OGEN 0001234880 KOSKI ROBERT C 1990 MAIN STREET, SUITE 750 SARASOTA FL 34236 1 0 0 0 0 Non-Employee Director Option (Right to Buy) 0.48 2024-09-19 4 A 0 65000 0 A 2024-09-19 2034-09-19 Common Stock 65000 65000 D Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant. /s/ Julio C. Esquivel, as Attorney-in-Fact for Robert Koski 2024-09-20